SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to ...

Amber Heard has one of the world’s most beautiful faces – that is, according to cosmetic surgeon Julian De Silva. The claim has been recycled for some years now, and recently resurfaced in the wake of ...

Set to launch this month, a recently approved blood test to detect biomarkers for Alzheimer’s disease could bring diagnosis into everyday clinical practice. In turn, this may support earlier ...

Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease diagnostic journey and enable earlier intervention through its accessibility and ...

Findings showed 91.7% of patients with positive results using Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test had amyloid plaques based on PET scan or CSF test results. The Food and Drug ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...